REFERENCES
1. New MI. Inborn errors of adrenal steroidogenesis. Mol Cell
Endocrinol . 2003;211(1-2):75-83. doi: 10.1016/j.mce.2003.09.013 .
2. Breil T, Yakovenko V, Inta I, et al. Typical characteristics of
children with congenital adrenal hyperplasia due to 11β-hydroxylase
deficiency: a single-centre experience and review of the literature.J Pediatr Endocrinol Metab . 2019;32(3):259-267. doi:10.1515/jpem-2018-0298 .
3. Bulsari K, Falhammar H. Clinical perspectives in congenital adrenal
hyperplasia due to 11β-hydroxylase deficiency. Endocrine .
2017;55(1):19-36. doi: 10.1007/s12020-016-1189-x .
4. Joehrer K, Geley S, Strasser-Wozak EM, et al. CYP11B1 mutations
causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase
deficiency. Hum Mol Genet . 1997;6(11):1829-1834. doi:10.1093/hmg/6.11.1829 .
5. Khémiri M, Ridane H, Bou YO, Matoussi N, Khaldi F. Le deficit en 11
beta hydroxylase: étude clinique a propos de sept observations [11
beta hydroxylase deficiency: a clinical study of seven cases].Tunis Med . 2006;84(2):106-113.
6. Zachmann M, Tassinari D, Prader A. Clinical and biochemical
variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase
deficiency. A study of 25 patients. J Clin Endocrinol Metab .
1983;56(2):222-229. doi: 10.1210/jcem-56-2-222 .
7. Rösler A, Leiberman E, Sack J, et al. Clinical variability of
congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.Horm Res . 1982;16(3):133-141. doi: 10.1159/000179494 .
8. Parajes S, Loidi L, Reisch N, et al. Functional consequences of seven
novel mutations in the CYP11B1 gene: four mutations associated with
nonclassic and three mutations causing classic 11{beta}-hydroxylase
deficiency. J Clin Endocrinol Metab . 2010;95(2):779-788. doi:10.1210/jc.2009-0651 .
9. Menabò S, Polat S, Baldazzi L, et al. Correction: congenital adrenal
hyperplasia due to 11-beta-hydroxylase deficiency: functional
consequences of four CYP11B1 mutations. Eur J Hum Genet .
2020;28(5):692. doi: 10.1038/s41431-020-0587-y .
10. Peters CJ, Nugent T, Perry LA, et al. Cosegregation of a novel
homozygous CYP11B1 mutation with the phenotype of non-classical
congenital adrenal hyperplasia in a consanguineous family. Horm
Res . 2007;67(4):189-193. doi: 10.1159/000097244 .
11. Entezari P, Kajbafzadeh AM, Mahjoub F, Vasei M. Leydig cell tumor in
two brothers with congenital adrenal hyperplasia due to 11-β hydroxylase
deficiency: a case report. Int Urol Nephrol . 2012;44(1):133-137.
doi:10.1007/s11255-010-9890-9https.org/10.1007/s12020-016-1189-x .
12. White PC. Steroid 11 beta-hydroxylase deficiency and related
disorders. Endocrinol Metab Clin North Am . 2001;30(1):61-79. doi:10.1016/S0889-8529(08)70019-7 .
13. Engels M, Pijnenburg-Kleizen KJ, Utari A, et al. Glucocorticoid
activity of adrenal steroid precursors in untreated patients with
congenital adrenal hyperplasia. J Clin Endocrinol Metab .
2019;104(11):5065-5072. doi: 10.1210/jc.2019-00547 .
14. Hellal-Levy C, Couette B, Fagart J, Souque A, Gomez-Sanchez C,
Rafestin-Oblin M. Specific hydroxylations determine selective
corticosteroid recognition by human glucocorticoid and mineralocorticoid
receptors. FEBS Lett . 1999;464(1-2):9-13. doi:10.1016/s0014-5793(99)01667-1 .
15. Peter M. Congenital adrenal hyperplasia: 11beta-hydroxylase
deficiency. Semin Reprod Med . 2002;20(3):249-254. doi:10.1055/s-2002-35389 .
16. Melcescu E, Phillips J, Moll G, Subauste JS, Koch CA.
11Beta-hydroxylase deficiency and other syndromes of mineralocorticoid
excess as a rare cause of endocrine hypertension. Horm Metab Res .
2012;44(12):867-878. doi: 10.1055/s-0032-1321851 .
17. Chabre O, Portrat-Doyen S, Chaffanjon P, et al. Bilateral
laparoscopic adrenalectomy for congenital adrenal hyperplasia with
severe hypertension, resulting from two novel mutations in splice donor
sites of CYP11B1. J Clin Endocrinol Metab . 2000;85(11):4060-4068.
doi: 10.1210/jcem.85.11.6897 .
18. Kacem M, Moussa A, Khochtali I, Nabouli R, Morel Y, Zakhama A.
Bilateral adrenalectomy for severe hypertension in congenital adrenal
hyperplasia due to 11beta-hydroxylase deficiency: long term follow-up.Ann endocrinol (Paris) . 2009;70(2):113-118. doi:10.1016/j.ando.2008.12.005 .
19. Fenichel P, Bstandig B, Roger C, et al. Unilateral testicular tumour
associated to congenital adrenal hyperplasia: failure of specific
tumoral molecular markers to discriminate between adrenal rest and
leydigioma. Ann endocrinol (Paris) . 2008;69(5):453-458. doi:10.1016/j.ando.2008.05.002 .
20. Bercovici JP, Fiet J, Gibault L, et al. Testicular adrenal rest
tumours in salt wasting congenital adrenal hyperplasia (in vivo and in
vitro studies). J Steroid Biochem Mol Biol . 2005;93(1):67-72.
doi: 10.1016/j.jsbmb.2004.10.023 .
21. Whittle E, Falhammar H. Glucocorticoid regimens in the Treatment of
Congenital Adrenal Hyperplasia: A systematic Review and Meta-Analysis.J Endocr Soc . 2019;3(6):1227-1245. doi:10.1210/js.2019-00136 .
22. Nasir J, Royston C, Walton C, White MC. 11 Beta-hydroxylase
deficiency: management of a difficult case by laparoscopic bilateral
adrenalectomy. Clin Endocrinol (Oxf) . 1996;45(2):225-228. doi:10.1046/j.1365-2265.1996.d01-1556.x .
23. Hinz L, Pacaud D, Kline G. Congenital adrenal hyperplasia causing
hypertension: an illustrative review. J Hum Hypertens .
2018;32(2):150-157. doi: 10.1038/s41371-017-0002-5 .